SecBot SecBot

JAGX

Jaguar Health, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001585608 Biotech & Drug Discovery
$2.37 +0.33 (+16.18%)
Oct 26 4:00 PM ET · prev $2.04
Market cap
$16.8M
Nano cap
Median target
$262.50
+10976% · range $262.50–262.50
Next earnings
Nov 12
in 17 days
1 year
−99.8%
from $1,076.25 · Oct 27
30 days
−60.6%
from $6.02
52-week range
$2.04–1,081.50
−100% from high · low Oct 23
Avg volume 20D
3.10M
Oct 6 spike 27.07M
Short interest
84.2K
≈6.6% of shares · −74.2%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q4 2024 13F · 0 exits
Filing reports
24
analyzed by SecBot
SecBot read BEARISH 10 reports · 90 days
Balance 9 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 9/10 ·Next Earnings date, Nov 12, 2026
Strongest BEARISH Jaguar Health is holding a special meeting on November 6, 2026, to seek stockholder approval for six…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q4 2024: 2 added (0 new), 0 trimmed or exited.

  • Short sellersCOVERING

    Short interest −74.2% to 84.2K shares. 1.0 days to cover, ≈6.6% of shares.

  • TrendDOWNTREND

    68% below its 50-day average. New closing low $2.04 on Oct 23.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 16.

Who's buying

13F· Q4 2024
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGADD50,657$51.2K
BANK OF AMERICA CORP /DE/ADD96$97.00
VANGUARD GROUP INCDOUBLED59,503$80.3K
BANK OF AMERICA CORP /DE/ADD75$101.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2025
12-month targets · 1 analysts

Price is below the lowest target. Median implies +10976%.Targets as of Jul 16, 2026.

Recent actions
DateFirmActionRating
May 19, 2025First Berlin
INITIATE
INITIATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
JAGX Q3 2026 Earnings Scheduled — 2026-11-12
Dec 21, 2026
FDA decision date
PDUFA: JAGX — Canalevia in diarrhea in dogs — 2026-12-21
FDA target action date 2026-12-21 for JAGX (Jaguar Health, Inc.). Drug: Canalevia. Indication: diarrhea in dogs. Current conditional Regulatory…
Recent
Oct 16, 2026
Trading halt
Halt Resumed: JAGX — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-16T13:30:39.000Z | Resumed 2026-10-16T13:40:39.000Z
Oct 16, 2026
Trading halt
Trading Halt: JAGX — LUDP (Volatility Trading Pause)
Jaguar Health, Inc. Cmn | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 13, 2026
Reg SHO list
Reg SHO Threshold: JAGX entered the threshold list
JAGUAR HEALTH INC COM PAR $0.0 | 5+ consecutive settlement days of fails-to-deliver ≥10k shares and ≥0.5% of shares outstanding
Oct 5, 2026
Trading halt
Halt Resumed: JAGX — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-05T14:09:38.000Z | Resumed 2026-10-05T14:14:38.000Z
Oct 5, 2026
Trading halt
Trading Halt: JAGX — LUDP (Volatility Trading Pause)
Jaguar Health, Inc. Cmn | Market: NASDAQ | Code: LUDP — Volatility Trading Pause

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Dec 11, 2025
MICEK JOHN
Director
AWARD7,377 sh
Dec 11, 2025
MICEK JOHN
Director
AWARD7,377 sh

Earnings setup

Estimates
Nov 12
reports in 17 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Reddit
Recent posts
r/pennystocks Neutral 10d ago
16 OCT 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
1 upvotes · 1 comments
All social signals and their track records

Short side

FINRA· Sep 30, 2026
84,156
shares short
-74.2%
vs prior settlement
1.0
days to cover
≈6.6%
of shares outstanding
On the Reg SHO threshold listsince Oct 13, 2026: persistent fails-to-deliver. View list
Trading halts
Oct 16, 2026Volatility PauseResumed
Oct 5, 2026Volatility PauseResumed
Oct 5, 2026Volatility PauseResumed
Oct 5, 2026Volatility PauseResumed
Sep 25, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Jaguar Health filed a new S-3 shelf registration to register up to $75 million of securities, replacing its prior…
S-3 — Impact 5/10
Oct 16, 2026 Trading halt
Halt Resumed: JAGX — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-16T13:30:39.000Z | Resumed 2026-10-16T13:40:39.000Z
Oct 8, 2026 SEC
Jaguar Health is holding a special meeting on November 6, 2026, to seek stockholder approval for six proposals that…
DEF 14A — Impact 8/10
Oct 5, 2026 SEC
Jaguar Health declared a special one-time dividend of Series R Convertible Preferred Stock, with each share converting…
8-K — Impact 7/10
Dec 11, 2025 Insider
MICEK JOHN was granted 7,377 shares
Director
Dec 11, 2025 Insider
MICEK JOHN was granted 7,377 shares
Director
Dec 31, 2024 Inst.
UBS Group AG — ADD
50,657 shares ($51.2K)
Dec 31, 2024 Inst.
BANK OF AMERICA CORP — ADD
96 shares ($97.00)

SecBot reports

24 filings · 0 bullish · 17 bearish · 1 mixed · 6 neutral
All JAGX filing & press-release reports (24)